VitaCyte specializes in the production and supply of GMP-grade purified-defined enzymes, specifically Clostridium histolyticum collagenase and protease enzymes, which are essential for cell and tissue dissociation in research and therapeutic applications. Their manufacturing process is robust and flexible, allowing for the customization of enzyme formulations and packaging to meet specific research needs. VitaCyte emphasizes the importance of comprehensive analytical testing methods to ensure that their products consistently meet the required specifications for various applications, thereby facilitating effective collaboration with researchers and commercial cell suppliers.

The company has a rich history in the development of purified collagenase-protease enzyme mixtures, significantly contributing to advancements in cell therapy, such as the successful treatment of Type 1 Diabetes through islet transplantation. VitaCyte's products are categorized into purified-defined collagenase and neutral protease enzymes, which are designed to provide high purity and consistency across different lots. This focus on quality and reliability helps researchers avoid the extensive lot qualification procedures typically associated with traditional collagenase products, ultimately streamlining the cell isolation process and enhancing the efficiency of therapeutic applications.

United States

Vitacyte's focus is to share their scientific knowledge and experience to help you produce high functional cell yields.VitaCyte’s co-founders, Bob McCarthy and Francis Dwulet, were key contributors to the development of the first commercial, purified collagenase-protease enzyme mixture used to prepare cells for subsequent transplantation.

Vitacyte

Company Details